Immunome posts Q3 2026 update with varegacestat PDUFA date and new ADC trial clearance
Immunome reaffirmed an April 2027 FDA decision date for varegacestat and said IND clearance for IM-1340 sets up a fourth clinical-stage program by year-end.
SEC filing